Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in canadians. Laryngoscope. 2003;113(7):1199–205.

PubMed  Article  Google Scholar 

DeConde AS, Soler ZM. Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy. 2016;30(2):134–9.

PubMed  Article  Google Scholar 

Tomoum MO, Klattcromwell C, DelSignore A, Ebert C, Senior BA. Depression and anxiety in chronic rhinosinusitis: depression/anxiety in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5(8):674–81.

PubMed  Article  Google Scholar 

Kaplan A. Canadian guidelines for chronic rhinosinusitis: clinical summary. Cam Fam Physician. 2013;59(12):1275–81.

Google Scholar 

Alt JA, Thomas AJ, Curtin K, Wong J, Rudmik L, Orlandi RR. Mortality risk in patients with chronic rhinosinusitis and its association to asthma: Chronic rhinosinusitis and mortality. Int Forum Allergy Rhinol. 2017;7(6):591–9.

PubMed  PubMed Central  Article  Google Scholar 

Husain Q, Sedaghat AR. Understanding and clinical relevance of chronic rhinosinusitis endotypes. Clin Otolaryngol. 2019;44(6):887–97.

PubMed  Article  Google Scholar 

Kuruvilla ME, Lee FEH, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clinic Rev Allerg Immunol. 2019;56(2):219–33.

Article  Google Scholar 

Smith M. Dupixent now approved by Health Canada for patients with severe asthma. Sanofi. 2020. http://sanoficanada.mediaroom.com/2020-11-17-DUPIXENT-R-dupilumab-injection-now-approved-by-Health-Canada-for-patients-with-severe-asthma. Accessed July 2021.

Product monograph, including patient medication information: Dupixent (Duplimab Injection). Sanofi-aventis Canada Inc.; 2020:1–70.

Hellings PW, Verhoeven E, Fokkens WJ. State-of-the-art overview on biological treatment for CRSwNP. Rhin. 2021;59(2):151–63.

CAS  Google Scholar 

Karp J, Dhillon I, Panchmatia R, Javer A. Subcutaneous mepolizumab injection: an adjunctive treatment for recalcitrant allergic fungal rhinosinusitis patients with asthma. Am J Rhinol Allergy. 2021;35(2):256–63.

PubMed  Article  Google Scholar 

Kaplan AP, Giménez-Arnau AM, Saini SS. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017;72(4):519–33.

CAS  PubMed  Article  Google Scholar 

Regulatory decision summary - Xolair - Health Canada. Government of Canada. 2021. https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00839. Accessed July 2021.

Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595–605.

CAS  PubMed  Article  Google Scholar 

Agache I, Song Y, Alonso-Coello P, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337–53.

CAS  PubMed  Article  Google Scholar 

CADTH Reimbursement Review Dupilumab (Dupixent). Canadian Journal of Health Technologies. 2021. https://cadth.ca/sites/default/files/cdr/complete/SR0667-combined%20clinical%20and%20PE%20report.pdf

Population size and growth in Canada: Key results from the 2016 Census. Statistics Canada. 2016. https://www150.statcan.gc.ca/n1/daily-quotidien/170208/dq170208a-eng.html. Accessed Dec 2021.

Thamboo A, Kilty S, Witterick I, et al. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. J of Otolaryngol Head Neck Surg. 2021;50(1):15.

Article  Google Scholar 

Harris P. Research electronic data capture (REDCap). J Med Libr Assoc. 2018;106(1):142–4.

Google Scholar 

Stevens WW, Peters AT, Tan BK, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol. 2019;7(8):2812–2820.e3.

Wang X, Zhang N, Bo M, et al. Diversity of T H cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138(5):1344–53.

CAS  PubMed  Article  Google Scholar 

Tan BK, Klingler AI, Poposki JA, et al. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. J Allergy Clin Immunol. 2017;139(2):699-703.e7.

PubMed  Article  Google Scholar 

Tyler MA, Russell CB, Smith DE, et al. Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes. J Allergy Clin Immunol. 2017;139(3):1061-1064.e4.

CAS  PubMed  Article  Google Scholar 

Delemarre T, Holtappels G, De Ruyck N, et al. Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype. J Allergy Clin Immunol. 2020;146(2):337-343.e6.

CAS  PubMed  Article  Google Scholar 

Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2020;58(Suppl S29):1–464.

PubMed  Google Scholar 

Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74(12):2312–9.

PubMed  Article  Google Scholar 

Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36.

CAS  PubMed  Article  Google Scholar 

Mustafa SS, Vadamalai K, Scott B, Ramsey A. Dupilumab as add-on therapy for chronic rhinosinusitis with nasal polyposis in aspirin exacerbated respiratory disease. Am J Rhino l Allergy. 2021;35(3):399–407.

Article  Google Scholar 

Lombardo N, Pelaia C, Ciriolo M, et al. Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma. Int J Immunopathol Pharmacol. 2020;34:1–8.

Article  CAS  Google Scholar 

Wuensch K. Binary Logistic Regression with SPSS. East Caroline University Department of Psychology. http://core.ecu.edu/psyc/wuenschk/MV/multReg/Logistic-SPSS.pdf

Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9.

CAS  PubMed  Article  Google Scholar 

Min JY, Tan BK. Risk factors for chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2015;15(1):1–13.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Asuero AG, Sayago A, González AG. The correlation coefficient: an overview. Crit Rev Anal Chem. 2006;36(1):41–59.

CAS  Article  Google Scholar 

Kariyawasam HH, James LK. Chronic Rhinosinusitis with nasal polyps: targeting IgE with anti-IgE Omalizumab therapy. DDDT. 2020;14:5483–94.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kanemitsu Y, Suzuki M, Fukumitsu K, et al. A novel pathophysiologic link between upper and lower airways in patients with chronic rhinosinusitis: association of sputum periostin levels with upper airway inflammation and olfactory function. World Allergy Organ J. 2020;13(1): 100094.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cao PP, Zhang YN, Liao B, et al. Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps. Clin Exp Allergy. 2014;44(5):690–700.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wei B, Liu F, Zhang J, et al. Multivariate analysis of inflammatory endotypes in recurrent nasal polyposis in a Chinese population. Rhin. 2018;56(3):216–26.

CAS  Article  Google Scholar 

Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol. 2017;12:331–57.

CAS  PubMed  Article  Google Scholar 

Khan AH, Reaney M, Guillemin I, et al. (2021) Development of Sinonasal Outcome Test (SNOT ‐22) domains in chronic rhinosinusitis with nasal polyps. Laryngoscope.

Rai G, Roy P, Gupta N, et al. Computed tomography score an excellent marker: differentiates eosinophilic and non-eosinophilic variants of chronic rhinosinusitis with nasal polyps. Indian J Otolaryngol Head Neck Surg. 2019;71(3):1787–92.

PubMed  Article  Google Scholar 

Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg. 2007;137(4):555–61.

PubMed  Article  Google Scholar 

Valencia V, Arora VM, Ranji SR, Meza C, Moriates C. A comparison of laboratory testing in teaching vs nonteaching hospitals for 2 common medical conditions. JAMA Intern Med. 2018;178(1):39.

PubMed  Article  Google Scholar 

Tan BK, Chandra RK, Pollak J, et al. Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2013;131(5):1350–60.

PubMed  PubMed Central  Article  Google Scholar 

Canada’s population clock (real-time model). Statistics Canada. https://www150.statcan.gc.ca/n1/pub/71-607-x/71-607-x2018005-eng.htm

McClernon A, Freeman A, Cheeley R, McClernon D. Cost Comparison of Shipping Frozen Plasma vs. Ambient Temperature using vivest. Vivebio.com. https://vivebio.com/wp-content/uploads/2017/09/2012-12-09-dart-cost-comparison-of-shipping-frozen-plasma-versus-ambient-temperature-using-vivest.pdf

Schedule of fees for laboratory services outpatient. British Columbia Ministry of Health. Published June 1, 2020. http://www.bccss.org/bcaplm-site/Documents/Programs/laboratory_services_schedule_of_fees.pdf. Accessed July 2021.

Restelli V, Taylor A, Cochrane D, Noble MA. Medical laboratory associated errors: the 33-month experience of an on-line volunteer Canadian province wide error reporting system. Diagnosis. 2017;4(2):79–86.

PubMed  Article  Google Scholar 

Thomas AJ, McCoul ED, Meier JD, Newberry CI, Smith TL, Alt JA. Cost and operative time estimation itemized by component procedures of endoscopic sinus surgery. Int Forum Allergy Rhinol. 2020;10(6):755–61.

PubMed  Article  Google Scholar 

Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2_suppl):S1–39.

PubMed  Article  Google Scholar 

Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198–207.

PubMed  Article  CAS  Google Scholar 

Armengot-Carceller M, Gómez-Gómez MJ, García-Navalón C, et al. Effects of omalizumab treatment in patients with recalcitrant nasal polyposis and mild asthma: a multicenter retrospective study. Am J Rhinol Allergy. 2021;35